Home・Aandelen Lijst・Haemonetics Corp

Haemonetics Corp

Open

SectorGezondheidszorg

107.87 -0.39

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

106.69

Max

108.62

Belangrijke statistieken
By Trading Economics
Inkomsten	53M 33M
Verkoop	-7M 339M
K/W Sectorgemiddelde	43.82 57.371
EPS	1.14
Winstmarge	9.727
Werknemers	3,009
EBITDA	70M 75M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	-5.55% downside

Dividenden
By Acuity
Volgende Winsten	5 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	163M 4.1B
Vorige openingsprijs	108.26
Vorige sluitingsprijs	107.87

Nieuwssentiment

By Acuity

100%

326 / 340 Rangschikking in Healthcare

Haemonetics Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 aug 2026, 19:46 UTC

Haemonetics Corp shares are lower today amid rising oil prices and geopolitical tensions. The stock rebounded earlier but has since declined in routine fluctuations.

21 aug 2026, 23:01 UTC

Haemonetics Corp is modestly higher in after-market trading, maintaining strength above its 20-day moving average and nearing the upper end of its one-month range.

20 aug 2026, 23:01 UTC

Haemonetics Corp shares are higher in after-market hours, nearing the top of their one-month trading range and above the 20-day moving average.

19 aug 2026, 23:41 UTC

Haemonetics Corp shares declined after-market, retracing from earlier gains. The asset remains above its 20-day moving average and near the upper end of its one-month range.

18 aug 2026, 23:42 UTC

Haemonetics Corp shares are trading lower in after-market hours, reflecting a decline from earlier highs, though remaining above the 20-day moving average.

17 aug 2026, 20:06 UTC

Haemonetics Corp shares are lower today, reflecting broader market pressures amid a notable drop in U.S. retail sales for July.

14 aug 2026, 19:51 UTC

Haemonetics Corp shares are higher today, supported by a positive trend in the Health Care Supplies sector and increased trading volume.

13 aug 2026, 19:51 UTC

Haemonetics shares are declining amid rising jobless claims and flat Producer Price Index data, breaking a recent trend of higher daily closes.

12 aug 2026, 20:01 UTC

Haemonetics Corp shares are higher today, supported by unusually high trading volume and a strong upward trajectory since Tuesday's close.

11 aug 2026, 20:06 UTC

Haemonetics Corp shares are higher today, maintaining a position near the upper end of their one-month range despite a minor pullback earlier in the session.

10 aug 2026, 19:46 UTC

Haemonetics Corp shares are declining amid broader market uncertainty following recent U.S. employment data, despite earlier gains during the session.

7 aug 2026, 22:01 UTC

News

Haemonetics shares are lower in after-market trading despite Citigroup raising its price target to $92 and maintaining a Neutral rating.

6 aug 2026, 21:01 UTC

Haemonetics Corp. shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

5 aug 2026, 19:31 UTC

Haemonetics Corp shares are lower today, breaking a trend of higher closes. The stock is experiencing unusually high trading volume amid no specific news.

4 aug 2026, 21:01 UTC

Haemonetics Corp shares declined in after-market hours, despite broader market gains from positive U.S.-Iran negotiations and falling crude oil prices.

3 aug 2026, 19:56 UTC

Haemonetics Corp shares are higher, reflecting broader market gains amid positive momentum in major tech stocks and easing geopolitical tensions.

31 jul 2026, 20:04 UTC

Haemonetics Corp shares are higher, with no specific news identified. The broader market has also gained since Thursday's close, recovering from earlier losses.

30 jul 2026, 19:48 UTC

Haemonetics Corp. shares are lower today, continuing a decline since Wednesday. The stock remains above its 20-day moving average despite recent downward movement.

29 jul 2026, 21:21 UTC

Haemonetics Corp shares are lower in after-market trading, reflecting broader declines in the equity market and Health Care Supplies sector amid rising oil prices.

28 jul 2026, 21:01 UTC

Haemonetics Corp shares are lower in after-market hours, following a broader market decline amid a significant drop in the Nikkei 225 Index.

27 jul 2026, 22:51 UTC

Haemonetics Corp shares are higher in after-market trading, supported by falling crude oil prices and strong performance above the 20-day moving average.

24 jul 2026, 20:31 UTC

Haemonetics Corp shares are lower in after-market hours, continuing a decline from Friday's close. No specific news was identified to explain the movement.

23 jul 2026, 23:21 UTC

Haemonetics Corp shares are lower in after-market trading, continuing a decline that began after Thursday's close, reaching the midpoint of their one-month trading range.

22 jul 2026, 20:13 UTC

Shares of Haemonetics Corp are trading higher in after-market hours, positioned above its 20-day moving average amid broader market volatility and rising crude oil prices.

20 jul 2026, 18:46 UTC

Haemonetics Corp shares are higher today, continuing gains since Friday's close. The stock reached a session high earlier, though it has pulled back.

Peer Vergelijking

Prijswijziging

Haemonetics Corp Prognose

Koersdoel

By TipRanks

-5.55% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 102.38 USD -5.55%

Hoogste 120 USD

Laagste 84 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Haemonetics Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Gebaseerd op 9 analisten die aandelenratings hebben gegeven aan Haemonetics Corp - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

326 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.